Hepatitis Monthly

Published by: Kowsar

Hepatitis B Viral DNA Among HBs Antigen Negative Healthy Blood Donors

Maryam Vaezjalali 1 , 2 , Shabnam Rashidpour 3 , Hanieh Rezaee 2 , Bashir Hajibeigi 4 , Majid Zeidi 4 , Latif Gachkar 1 , Shadi Aghamohamad 2 , Ronak Najafi 2 and Hossein Goudarzi 1 , 2 , *
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Microbiology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Department of Immunology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
4 Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, IR Iran
Article information
  • Hepatitis Monthly: March 01, 2013, 13 (3); e6590
  • Published Online: March 17, 2013
  • Article Type: Research Article
  • Received: June 25, 2012
  • Revised: July 15, 2012
  • Accepted: July 31, 2012
  • DOI: 10.5812/hepatmon.6590

To Cite: Vaezjalali M, Rashidpour S, Rezaee H, Hajibeigi B, Zeidi M, et al. Hepatitis B Viral DNA Among HBs Antigen Negative Healthy Blood Donors, Hepat Mon. 2013 ; 13(3):e6590. doi: 10.5812/hepatmon.6590.

Copyright © 2013, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007; 16(4): 403-6[PubMed]
  • 2. Chemin I, Trepo C. Clinical impact of occult HBV infections. J Clin Virol. 2005; 34 Suppl 1-21[PubMed]
  • 3. van Hemert FJ, Zaaijer HL, Berkhout B, Lukashov VV. Occult hepatitis B infection: an evolutionary scenario. Virol J. 2008; 5: 146[DOI][PubMed]
  • 4. Saraswat S, Banerjee K, Chaudhury N, Mahant T, Khandekar P, Gupta RK, et al. Post-transfusion hepatitis type B following multiple transfusions of HBsAg-negative blood. J Hepatol. 1996; 25(5): 639-43[PubMed]
  • 5. Liu CJ, Lo SC, Kao JH, Tseng PT, Lai MY, Ni YH, et al. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. J Hepatol. 2006; 44(1): 39-46[DOI][PubMed]
  • 6. Datta S, Banerjee A, Chandra PK, Chakraborty S, Basu SK, Chakravarty R. Detection of a premature stop codon in the surface gene of hepatitis B virus from an HBsAg and antiHBc negative blood donor. J Clin Virol. 2007; 40(3): 255-8[DOI][PubMed]
  • 7. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol. 2007; 46(1): 160-70[DOI][PubMed]
  • 8. Vitale F, Tramuto F, Orlando A, Vizzini G, Meli V, Cerame G, et al. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection? J Med Virol. 2008; 80(4): 577-82[DOI][PubMed]
  • 9. Dufour DR. Hepatitis B surface antigen (HBsAg) assays--are they good enough for their current uses? Clin Chem. 2006; 52(8): 1457-9[DOI][PubMed]
  • 10. Poorolajal J, Majdzadeh R. Prevalence of chronic hepatitis B infection in Iran: a review article. J Res Med Sci. 2009; 14(4): 249-58[PubMed]
  • 11. Jazayeri MS, Basuni AA, Cooksley G, Locarnini S, Carman WF. Hepatitis B virus genotypes, core gene variability and ethnicity in the Pacific region. J Hepatol. 2004; 41(1): 139-46[DOI][PubMed]
  • 12. Ranjbar M, Golzardi Z, Sedigh L, Nekoozadeh S. Intrafamilial seropositivity of hepatitis in patients with hepatitis B and C virus in hepatitis clinic in Hamadan, Iran. Ann Hepatol. 2012; 11(1): 32-6[PubMed]
  • 13. Toukan AU. Hepatitis B in the Middle East: aspects of epidemiology and liver disease after infection. Gut. 1996; 38 Suppl 2-4[PubMed]
  • 14. Conjeevaram HS, Lok AS. Occult hepatitis B virus infection: a hidden menace? Hepatology. 2001; 34(1): 204-6[DOI][PubMed]
  • 15. Yuan Q, Ou SH, Chen CR, Ge SX, Pei B, Chen QR, et al. Molecular characteristics of occult hepatitis B virus from blood donors in southeast China. J Clin Microbiol. 2010; 48(2): 357-62[DOI][PubMed]
  • 16. Aguiar JI, Aguiar E, Paniago A, Cunha R, Galvao L, Daher R. Prevalence of antibodies to hepatitis B core antigen in blood donors in the middle West region of Brazil. Mem Inst Oswaldo Cruz. 2001; 96(2): 185-7[PubMed]
  • 17. Almeida RP, Cardoso DD. Detection of HBV DNA by nested-PCR in a HBsAg and anti-HBc negative blood bank donor. J Clin Virol. 2006; 36(3): 231-4[DOI][PubMed]
  • 18. Delavari M, Shahabinejhad N, Renzaho A, Zahedi M, Owhadi AR. J blood disorders transfusion. 2011; 2(1): 1-4
  • 19. Khamesipour A, Amiri ZM, Kafiabad SA, Saadat F, Mansour-ghanaei F, Esteghamati AR, et al. Frequency of hepatitis B virus DNA in anti-HBc positive, HBsAg negative blood donors in Rasht, northern Iran. Transfus Apher Sci. 2011; 45(2): 195-7[DOI][PubMed]
  • 20. Sofian M, Aghakhani A, Izadi N, Banifazl M, Kalantar E, Eslamifar A, et al. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran. Int J Infect Dis. 2010; 14(4)-10[DOI][PubMed]
  • 21. Jafarzadeh A, Arababadi MK, Pourazar MMA. Occult hepatitis B virus infection among blood donors with antibodies to hepatitis B core antigen. Acta Medica Iranica. 2008; 46(1): 27-32
  • 22. Pourazar A, Salehi M, Jafarzadeh A, Arababadi MK, Oreizi F, Shariatinezhad K. Detection of HBV DNA in HBsAg negative normal blood donors. IJI. 2005; 2(3): 172-6
  • 23. Behzad-Behbahani A, Mafi-Nejad A, Tabei SZ, Lankarani KB, Torab A, Moaddeb A. Indian J Med Res. 2006; 123(1): 37-42[PubMed]
  • 24. Jeremiah ZA, Idris H, Ajayi BB, Ezimah AC, Malah MB, Baba MM. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria. Hum Antibodies. 2011; 20(3-4): 77-82[DOI][PubMed]
  • 25. Yoshiba M, Sekiyama K, Sugata F, Kawamoto Y, Muraoka H, Aoyama M. Post-transfusion fulminant hepatitis B after screening for hepatitis B virus core antibody. Lancet. 1992; 339(8787): 253-4[PubMed]
  • 26. Niederhauser C. Reducing the risk of hepatitis B virus transfusion-transmitted infection. J Blood Med. 2011; 2: 91-102[DOI][PubMed]
  • 27. Seo DH, Whang DH, Song EY, Kim HS, Park Q. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors. Transfusion. 2011; 51(8): 1840-6
  • 28. Shastry S, Bhat SS. Prevention of post-transfusion hepatitis by screening of antibody to hepatitis B core antigen in healthy blood donors. Mediterr J Hematol Infect Dis. 2011; 3(1)[DOI][PubMed]
  • 29. Makroo RN, Chowdhry M, Bhatia A, Arora B, Rosamma NL. Hepatitis B core antibody testing in Indian blood donors: A double-edged sword! Asian J Transfus Sci. 2012; 6(1): 10-3[DOI][PubMed]
  • 30. Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Anti–hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Transfusion. 2007; 47(1): 74-9
  • 31. Arabaci F, Oldacay M. Investigation of mutant hepatitis B virus in core antibody seropositive cases of blood donor population. J Med Sci. 2008; 8(3): 316-20
  • 32. Findik D, Arslan U, Baykan M. Determination of hepatitis B virus DNA incidence, viral load, and mutations in blood donors with HBsAg and anti-HBs-negative serology and antibodies to hepatitis B core antigen. Eur J Intern Med. 2007; 18(8): 571-5[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments